Kandai Nozu

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

Medicine, Nephrology, Pediatrics +14

Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group

Clifford E. Kashtan, Jie Ding, Guido Garosi et al. · Kidney International · 2018 · 319 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Anna Köttgen, Émilie Cornec-Le Gall, Jan Halbritter et al. · Kidney International · 2022 · 187 citations · Full text

Life Sciences, Genetics, Nephrology +17

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

Koichi Kamei, Shuichi Ito, Kandai Nozu et al. · Pediatric Nephrology · 2009 · 175 citations

Medicine, Nephrology, Pediatrics +10

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

Kazumoto Iijima, Kiyoshi Hamahira, Ryojiro Tanaka et al. · Kidney International · 2002 · 144 citations · Full text

Medicine, Nephrology, Pediatrics +15